HomeThe Oncologist current issue EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma byLists of AZ •1:29 PM 0 from The Oncologist current issue https://ift.tt/2uL0a4v Tags: The Oncologist current issue Facebook Twitter
